Provided by Tiger Trade Technology Pte. Ltd.

Evolent Health

3.39
-0.1000-2.87%
Post-market: 3.390.00000.00%16:10 EDT
Volume:1.97M
Turnover:6.71M
Market Cap:383.27M
PE:-0.75
High:3.51
Open:3.48
Low:3.34
Close:3.49
52wk High:8.59
52wk Low:2.10
Shares:113.06M
Float Shares:94.15M
Volume Ratio:0.75
T/O Rate:2.10%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.5419
EPS(LYR):-5.0732
ROE:-66.97%
ROA:-0.78%
PB:1.00
PE(LYR):-0.67

Loading ...

Jul 03, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 15, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 14, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 13, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 12, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 12, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 12, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 09, 2023

Major Issues Report

Form 8-K - Current report
Jun 01, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 23, 2023

Major Issues Report

Form 8-K - Current report
May 08, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
May 04, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 03, 2023

Major Issues Report

8-K - Current report
Apr 26, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Apr 19, 2023

Major Issues Report

8-K - Current report
Mar 29, 2023

Major Issues Report

8-K - Current report
Mar 08, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 24, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 22, 2023

Major Issues Report

8-K - Current report
Feb 15, 2023

Major Issues Report

8-K - Current report